BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25683334)

  • 1. Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations.
    Gambino G; Tancredi M; Falaschi E; Aretini P; Caligo MA
    Int J Mol Med; 2015 Apr; 35(4):950-6. PubMed ID: 25683334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
    Silva FC; Lisboa BC; Figueiredo MC; Torrezan GT; Santos EM; Krepischi AC; Rossi BM; Achatz MI; Carraro DM
    BMC Med Genet; 2014 May; 15():55. PubMed ID: 24884479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer.
    Belogianni I; Apessos A; Mihalatos M; Razi E; Labropoulos S; Petounis A; Gaki V; Keramopoulos A; Pandis N; Kyriacou K; Hadjisavvas A; Kosmidis P; Yannoukakos D; Nasioulas G
    BMC Cancer; 2004 Sep; 4():61. PubMed ID: 15353005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA2 T2722R is a deleterious allele that causes exon skipping.
    Fackenthal JD; Cartegni L; Krainer AR; Olopade OI
    Am J Hum Genet; 2002 Sep; 71(3):625-31. PubMed ID: 12145750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals.
    De Silva W; Karunanayake EH; Tennekoon KH; Allen M; Amarasinghe I; Angunawala P; Ziard MH
    BMC Cancer; 2008 Jul; 8():214. PubMed ID: 18662409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of clinically important BRCA gene mutations in ovarian cancer patients using next generation sequencing analysis.
    Zhang Y; Ali A; Xie J
    Am J Cancer Res; 2023; 13(10):5005-5020. PubMed ID: 37970354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous detection of genetic and copy number alterations in
    Hirotsu Y; Ooka Y; Sakamoto I; Nakagomi H; Omata M
    Oncotarget; 2017 Dec; 8(70):114463-114473. PubMed ID: 29383094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics analysis of hereditary breast and ovarian cancer patients in India.
    Soumittra N; Meenakumari B; Parija T; Sridevi V; Nancy KN; Swaminathan R; Rajalekshmy KR; Majhi U; Rajkumar T
    Hered Cancer Clin Pract; 2009 Aug; 7(1):13. PubMed ID: 19656415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel
    Colombo M; Mondini P; Minenza E; Foglia C; Mosconi A; Molica C; Pistola L; Ludovini V; Radice P
    Front Oncol; 2023; 13():1102184. PubMed ID: 37025588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new BRCA2 large genomic deletion associated with high risk male breast cancer.
    Timoteo AR; Albuquerque BM; Moura PC; Ramos CC; Agnez-Lima LF; Walsh T; King MC; Lajus TB
    Hered Cancer Clin Pract; 2015; 13(1):2. PubMed ID: 25632310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variant.
    Block I; Mateu-Regué À; Do TTN; Miceikaite I; Sdogati D; Larsen MJ; Hao Q; Nielsen HR; Boonen SE; Skytte AB; Jensen UB; Høffding LK; De Nicolo A; Viel A; Tudini E; Parsons MT; Hansen TVO; Rossing M; Kruse TA; Spurdle AB; Thomassen M
    Breast Cancer Res; 2024 Jan; 26(1):6. PubMed ID: 38195559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the
    Sanoguera-Miralles L; Valenzuela-Palomo A; Bueno-Martínez E; Llovet P; Díez-Gómez B; Caloca MJ; Pérez-Segura P; Fraile-Bethencourt E; Colmena M; Carvalho S; Allen J; Easton DF; Devilee P; Vreeswijk MPG; de la Hoya M; Velasco EA
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33333735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays.
    Biswas K; Lipton GB; Stauffer S; Sullivan T; Cleveland L; Southon E; Reid S; Magidson V; Iversen ES; Sharan SK
    NPJ Genom Med; 2020 Dec; 5(1):52. PubMed ID: 33293522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant alternative splicing in breast cancer.
    Yang Q; Zhao J; Zhang W; Chen D; Wang Y
    J Mol Cell Biol; 2019 Oct; 11(10):920-929. PubMed ID: 31065692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Genetic Markers with the Risk of Early-Onset Breast Cancer in Kazakh Women.
    Skvortsova L; Abdikerim S; Yergali K; Mit N; Perfilyeva A; Omarbayeva N; Zhunussova A; Kachiyeva Z; Sadykova T; Bekmanov B; Kaidarova D; Djansugurova L; Zhunussova G
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: A novel
    Colombo M; Mondini P; Minenza E; Foglia C; Mosconi A; Molica C; Pistola L; Ludovini V; Radice P
    Front Oncol; 2023; 13():1306238. PubMed ID: 37936611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic.
    Ahlborn LB; Dandanell M; Steffensen AY; Jønson L; Nielsen FC; Hansen TV
    Breast Cancer Res Treat; 2015 Apr; 150(2):289-98. PubMed ID: 25724305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples.
    Fackenthal JD; Yoshimatsu T; Zhang B; de Garibay GR; Colombo M; De Vecchi G; Ayoub SC; Lal K; Olopade OI; Vega A; Santamariña M; Blanco A; Wappenschmidt B; Becker A; Houdayer C; Walker LC; López-Perolio I; Thomassen M; Parsons M; Whiley P; Blok MJ; Brandão RD; Tserpelis D; Baralle D; Montalban G; Gutiérrez-Enríquez S; Díez O; Lazaro C; ; Spurdle AB; Radice P; de la Hoya M
    J Med Genet; 2016 Aug; 53(8):548-58. PubMed ID: 27060066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes.
    Lai S; Brookes C; Prosser DO; Lan CC; Doherty E; Love DR
    Sultan Qaboos Univ Med J; 2015 Feb; 15(1):e58-70. PubMed ID: 25685387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.
    Villarreal-Garza C; Weitzel JN; Llacuachaqui M; Sifuentes E; Magallanes-Hoyos MC; Gallardo L; Alvarez-Gómez RM; Herzog J; Castillo D; Royer R; Akbari M; Lara-Medina F; Herrera LA; Mohar A; Narod SA
    Breast Cancer Res Treat; 2015 Apr; 150(2):389-94. PubMed ID: 25716084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.